Weighted Average Number of Shares Outstanding, Diluted of Pelthos Therapeutics Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Pelthos Therapeutics Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Pelthos Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 3,061,488, a 429% increase year-over-year.
  • Pelthos Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 5,574,473, a 337% increase from 2023.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Pelthos Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 3,061,488 +2,482,259 +429% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 640,518 +63,147 +11% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 6,127,924 +1,436,935 +31% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 5,574,473 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 579,229 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 577,371 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 4,690,989 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1

Pelthos Therapeutics Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 5,574,473 +4,297,930 +337% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 1,276,543 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.